TD Cowen sets USD 110.00 target for Medtronic stock

Published on 10/06/2026 at 13:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 revenue rose 13.70 percent to USD 9.76 billion. Medtronic stock costs EUR 78.47 on October 6, 2026 after EUR 78.54, minus 0.09 percent.

Geometrisches Bauhaus-Poster mit bunten Formen und dem Schriftzug MEDTECH — Medtronic plc (ISIN IE00BTN1Y115) Bauhaus-Poster präsentiert geometrische Formen mit dem Sektor-Schriftzug MEDTECH prominent, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) has a USD 110.00 price target from TD Cowen, while its stock was trading at EUR 78.47 at Lang & Schwarz on October 6, 2026 at 1:46 p.m. CEST. According to MarketBeat on September 30, 2026, TD Cowen restated a Buy rating and set the target at USD 110.00.

Two devices gain coding approvals

On October 1, 2026, Medtronic said the American Medical Association approved permanent Category I CPT codes for its Altaviva implantable tibial neuromodulation device and Symplicity Spyral renal denervation system. The codes replace Category III codes and become effective in January 2028, supporting the reimbursement pathway while the company states that coding alone does not determine coverage or patient access.

Revenue growth lifts guidance

Zacks reported that Medtronic's fiscal 2027 first-quarter revenue reached USD 9.76 billion, up 13.70 percent year over year, while adjusted earnings per share rose to USD 1.45, up 15.10 percent. Revenue exceeded the USD 9.55 billion consensus estimate by 3.00 percent, giving the comparison more weight than the headline growth rate alone.

Medtronic raised fiscal 2027 organic revenue growth guidance to 7.25-7.75 percent from 6.75-7.25 percent. Adjusted earnings guidance moved to USD 5.94-6.00 per share from USD 5.90-6.00, but Zacks also described margin execution, tariffs and competitive pressure as constraints on the outlook.

MiniMed offer expires October 9

The company's MiniMed exchange offer is scheduled to expire at midnight New York time on October 9, 2026, unless extended or terminated, according to the SEC. The filing covers up to 225,361,295 MiniMed shares and describes an exchange value at a 7.00 percent discount to MiniMed's market value, subject to a cap.

Medtronic was trading at EUR 78.47 at Lang & Schwarz on October 6, 2026 at 1:46 p.m. CEST, minus 0.09 percent versus the Lang & Schwarz prior close of EUR 78.54 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.